Oramorph Oral Drops 20 Mg/Ml 20 mg SOLUTION
PDF Leaflet Revision Date: 20 September 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of severe pain in adults.
Dosage (summary)
Adults: 0.5-3 ml (8-48 drops) per dose, up to 18 ml daily.
Onset of Action / Duration
Onset: 30-90 mins, Duration: 4-6 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may cause withdrawal in infants.
Key Drug Interactions
- Sedatives (e.g., benzodiazepines)
- Rifampicin
- Cimetidine
- Anticholinergics
Contraindications
- Hypersensitivity to morphine
- Ileus
- Acute abdomen
- Head injury
- Compromised airways
- Pregnancy
- Lactation
Common side effects
- Nausea
- Vomiting
- Constipation
- Drowsiness
- Confusion
Counselling Points
- Monitor for signs of respiratory depression.
- Avoid abrupt discontinuation.
- Use effective contraception during treatment.
Serious warnings
- Risk of respiratory depression
- Opioid dependence
- Adrenal insufficiency
- Increased risk of ileus post-surgery
Important Disclaimer
The Oramorph Oral Drops 20 Mg/Ml 20 mg SOLUTION professional information leaflet below is the property of Eurolab and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
